CRISPR/Cas9 therapeutics: progress and prospects

Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) gene-editing technology is the ideal tool of the future for treating diseases by permanently correcting deleterious base mutations or disrupting disease-causing genes with great precision and effici...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tianxiang, Yang, Yanyan, Qi, Hongzhao, Cui, Weigang, Zhang, Lin, Fu, Xiuxiu, He, Xiangqin, Liu, Meixin, Li, Pei-feng, Yu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841506/
https://www.ncbi.nlm.nih.gov/pubmed/36646687
http://dx.doi.org/10.1038/s41392-023-01309-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841506/
https://www.ncbi.nlm.nih.gov/pubmed/36646687
http://dx.doi.org/10.1038/s41392-023-01309-7

Ejemplares similares